BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24001777)

  • 1. RNF43 mutations are recurrent in Chinese patients with mucinous ovarian carcinoma but absent in other subtypes of ovarian cancer.
    Zou Y; Wang F; Liu FY; Huang MZ; Li W; Yuan XQ; Huang OP; He M
    Gene; 2013 Nov; 531(1):112-6. PubMed ID: 24001777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological significance of somatic RNF43 mutation and aberrant expression of ring finger protein 43 in intraductal papillary mucinous neoplasms of the pancreas.
    Sakamoto H; Kuboki Y; Hatori T; Yamamoto M; Sugiyama M; Shibata N; Shimizu K; Shiratori K; Furukawa T
    Mod Pathol; 2015 Feb; 28(2):261-7. PubMed ID: 25081753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of
    Zou Y; Huang MZ; Liu FY; Yang BC; Wang LQ; Wang F; Yu XH; Wan L; Wan XD; Xu XY; Li W; Huang OP; He M
    Biomed Rep; 2015 Jan; 3(1):33-37. PubMed ID: 25469243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary.
    Ryland GL; Hunter SM; Doyle MA; Rowley SM; Christie M; Allan PE; Bowtell DD; ; Gorringe KL; Campbell IG
    J Pathol; 2013 Feb; 229(3):469-76. PubMed ID: 23096461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent POLE1 p.S297F mutation in Chinese patients with ovarian endometrioid carcinoma.
    Zou Y; Liu FY; Liu H; Wang F; Li W; Huang MZ; Huang Y; Yuan XQ; Xu XY; Huang OP; He M
    Mutat Res; 2014 Mar; 761():49-52. PubMed ID: 24472300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel somatic MAPK1 mutation in primary ovarian mixed germ cell tumors.
    Zou Y; Deng W; Wang F; Yu XH; Liu FY; Yang BC; Huang MZ; Guo JB; Xie QH; He M; Huang OP
    Oncol Rep; 2016 Feb; 35(2):725-30. PubMed ID: 26548627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and clinicopathological features of appendiceal mucinous neoplasms.
    Yanai Y; Saito T; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Tomita S; Hirai S; Ogura K; Matsumoto T; Wada R; Yao T
    Virchows Arch; 2021 Mar; 478(3):413-426. PubMed ID: 32821969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPP2R1A mutation is a rare event in ovarian carcinoma across histological subtypes.
    Rahman M; Nakayama K; Rahman MT; Nakayama N; Katagiri H; Katagiri A; Ishibashi T; Ishikawa M; Iida K; Otsuki Y; Nakayama S; Miyazaki K
    Anticancer Res; 2013 Jan; 33(1):113-8. PubMed ID: 23267135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infrequent mutations of the PPP2R1A and PPP2R1B genes in patients with ovarian cancer.
    Wang F; Zou Y; Liu FY; Yu XH; Huang H; Zhang N; Qi YY; Liu RF; Liu XY; Chen J; Huang OP; He M
    Mol Med Rep; 2013 Jun; 7(6):1826-30. PubMed ID: 23588898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
    Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
    Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mutations of PPP2R1A in ovarian and uterine carcinomas.
    Shih IeM; Panuganti PK; Kuo KT; Mao TL; Kuhn E; Jones S; Velculescu VE; Kurman RJ; Wang TL
    Am J Pathol; 2011 Apr; 178(4):1442-7. PubMed ID: 21435433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma.
    Gemignani ML; Schlaerth AC; Bogomolniy F; Barakat RR; Lin O; Soslow R; Venkatraman E; Boyd J
    Gynecol Oncol; 2003 Aug; 90(2):378-81. PubMed ID: 12893203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ring finger protein 43 expression is associated with genetic alteration status and poor prognosis among patients with intrahepatic cholangiocarcinoma.
    Talabnin C; Janthavon P; Thongsom S; Suginta W; Talabnin K; Wongkham S
    Hum Pathol; 2016 Jun; 52():47-54. PubMed ID: 26980022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNF43 is frequently mutated in colorectal and endometrial cancers.
    Giannakis M; Hodis E; Jasmine Mu X; Yamauchi M; Rosenbluh J; Cibulskis K; Saksena G; Lawrence MS; Qian ZR; Nishihara R; Van Allen EM; Hahn WC; Gabriel SB; Lander ES; Getz G; Ogino S; Fuchs CS; Garraway LA
    Nat Genet; 2014 Dec; 46(12):1264-6. PubMed ID: 25344691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.
    Wu J; Jiao Y; Dal Molin M; Maitra A; de Wilde RF; Wood LD; Eshleman JR; Goggins MG; Wolfgang CL; Canto MI; Schulick RD; Edil BH; Choti MA; Adsay V; Klimstra DS; Offerhaus GJ; Klein AP; Kopelovich L; Carter H; Karchin R; Allen PJ; Schmidt CM; Naito Y; Diaz LA; Kinzler KW; Papadopoulos N; Hruban RH; Vogelstein B
    Proc Natl Acad Sci U S A; 2011 Dec; 108(52):21188-93. PubMed ID: 22158988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma.
    Jiang X; Hao HX; Growney JD; Woolfenden S; Bottiglio C; Ng N; Lu B; Hsieh MH; Bagdasarian L; Meyer R; Smith TR; Avello M; Charlat O; Xie Y; Porter JA; Pan S; Liu J; McLaughlin ME; Cong F
    Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12649-54. PubMed ID: 23847203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.
    Fennell LJ; Clendenning M; McKeone DM; Jamieson SH; Balachandran S; Borowsky J; Liu J; Kawamata F; Bond CE; Rosty C; Burge ME; Buchanan DD; Leggett BA; Whitehall VLJ
    Fam Cancer; 2018 Jan; 17(1):63-69. PubMed ID: 28573495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two types of primary mucinous ovarian tumors can be distinguished based on their origin.
    Simons M; Simmer F; Bulten J; Ligtenberg MJ; Hollema H; van Vliet S; de Voer RM; Kamping EJ; van Essen DF; Ylstra B; Schwartz LE; Wang Y; Massuger LF; Nagtegaal ID; Kurman RJ
    Mod Pathol; 2020 Apr; 33(4):722-733. PubMed ID: 31695154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.
    Tan MC; Basturk O; Brannon AR; Bhanot U; Scott SN; Bouvier N; LaFemina J; Jarnagin WR; Berger MF; Klimstra D; Allen PJ
    J Am Coll Surg; 2015 May; 220(5):845-854.e1. PubMed ID: 25840541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of 103 ovarian serous and mucinous tumors.
    Vereczkey I; Serester O; Dobos J; Gallai M; Szakács O; Szentirmay Z; Tóth E
    Pathol Oncol Res; 2011 Sep; 17(3):551-9. PubMed ID: 21136228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.